MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 35.630
- +0.040+0.11%
Close Dec 20 16:00 ET
- 35.500
- -0.130-0.36%
Post 20:01 ET
5.63BMarket Cap-14.60P/E (TTM)
36.400High35.050Low4.06MVolume35.860Open35.590Pre Close145.19MTurnover2.59%Turnover RatioLossP/E (Static)157.90MShares54.44552wk High8.49P/B5.58BFloat Cap33.33052wk Low--Dividend TTM156.65MShs Float86.582Historical High--Div YieldTTM3.79%Amplitude2.500Historical Low35.732Avg Price1Lot Size
Ionis Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.47%-114.99M | -23.13%-119.88M | -11.90%-149.94M | -12.08%-307.51M | 116.42%32.87M | -346.28%-109.02M | -438.04%-97.36M | -323.36%-133.99M | -990.84%-274.37M | -198.29%-200.2M |
| Net income from continuing operations | 4.70%-140.48M | 22.31%-66.27M | -14.86%-142.8M | -35.80%-366.29M | 82.33%-9.26M | -213.69%-147.41M | 18.88%-85.29M | -90.78%-124.32M | -843.18%-269.72M | -123.34%-52.43M |
| Operating gains losses | -101.82%-261K | 132.13%3.79M | -325.77%-2.2M | 104.53%6.67M | 102.10%3.14M | 3,687.07%14.35M | -1,402.98%-11.79M | 55.34%974K | -1,538.68%-147.35M | -5,957.97%-149.26M |
| Depreciation and amortization | -1.75%5.49M | -1.93%5.58M | 0.80%5.65M | 1.78%22.5M | -20.16%5.61M | 9.74%5.59M | 11.86%5.69M | 14.53%5.61M | 13.01%22.11M | 41.03%7.03M |
| Other non cash items | 44.16%5.87M | 57.67%10.2M | -23.73%12.85M | 457.23%29.94M | 90.36%2.55M | 202.45%4.07M | 381.04%6.47M | 1,154.58%16.85M | 8.37%5.37M | 502.70%1.34M |
| Change In working capital | -129.99%-8.46M | -197.89%-94.03M | 17.24%-45.52M | -1,120.47%-77.26M | 142.06%12.99M | 60.45%-3.68M | -161.28%-31.56M | -1,362.48%-55M | 106.65%7.57M | 44.06%-30.88M |
| -Change in receivables | 108.15%9.33M | -59.38%-22.12M | 696.95%92.64M | -298.19%-72.06M | 336.89%44.76M | -108,175.47%-114.56M | -171.64%-13.88M | -67.51%11.62M | 154.11%36.36M | 64.24%-18.89M |
| -Change in inventory | 382.29%271K | 146.02%1.54M | -998.20%-1.83M | -330.51%-6.39M | -101.08%-2.79M | 88.49%-96K | -179.08%-3.34M | -121.58%-167K | 197.61%2.77M | 26.01%-1.39M |
| -Change in payables and accrued expense | 122.14%13.69M | -66.70%12.11M | -47.54%-102.95M | -63.61%21.16M | 113.23%48.42M | -9.38%6.16M | -0.99%36.36M | -764.70%-69.77M | 240.82%58.16M | 2.11%22.71M |
| -Change in other current assets | -10.58%1.23M | 8.98%-22.76M | 151.90%13.38M | -20.90%-29.84M | 51.40%-11.52M | 244.47%1.37M | -448.16%-25.01M | 173.55%5.31M | -2,714.37%-24.68M | -110.89%-23.69M |
| -Change in other working capital | -131.87%-32.97M | -144.35%-62.79M | -2,237.95%-46.76M | 115.17%9.87M | -585.63%-65.88M | 817.28%103.45M | -60.73%-25.7M | 92.01%-2M | 21.75%-65.04M | 16.44%-9.61M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5.47%-114.99M | -23.13%-119.88M | -11.90%-149.94M | -12.08%-307.51M | 116.42%32.87M | -346.28%-109.02M | -438.04%-97.36M | -323.36%-133.99M | -990.84%-274.37M | -198.29%-200.2M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -595.98%-340.8M | -10.16%62.45M | 123.37%76.11M | 18.47%-214.13M | -112.59%-26.71M | 137.36%68.71M | 2,203.96%69.52M | -13.25%-325.64M | -234.75%-262.64M | 123.06%212.15M |
| Net PPE purchase and sale | -322.98%-9.06M | 48.10%-6.23M | 57.10%-4.49M | -51.42%-23.81M | 119.79%819K | 61.37%-2.14M | -260.15%-12.01M | -287.13%-10.47M | -31.50%-15.72M | -65.43%-4.14M |
| Net intangibles purchase and sale | 1,259.09%12.75M | -1,222.05%-14.03M | 1.28%-1.24M | 3.93%-4.21M | 8.65%-792K | 27.54%-1.1M | 9.08%-1.06M | -51.69%-1.25M | 26.37%-4.38M | 41.69%-867K |
| Net investment purchase and sale | -578.78%-344.49M | 0.15%82.71M | 126.07%81.84M | 62.52%-186.14M | 27.53%-26.76M | 140.68%71.95M | 6,793.74%82.59M | -10.53%-313.92M | -333.37%-496.62M | -137.27%-36.93M |
| Net other investing changes | ---- | ---- | ---- | -99.99%22K | ---- | ---- | ---- | ---- | --254.08M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -595.98%-340.8M | -10.16%62.45M | 123.37%76.11M | 18.47%-214.13M | -112.59%-26.71M | 137.36%68.71M | 2,203.96%69.52M | -13.25%-325.64M | -234.75%-262.64M | 123.06%212.15M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,637.32%496.05M | -98.22%2.56M | -95.21%23.57M | 1,264.81%644.08M | 179.82%40.72M | -1,859.38%-32.27M | 11,713.83%143.54M | 6,817.91%492.09M | -122.48%-55.3M | 18.36%-51.02M |
| Net issuance payments of debt | 99.93%-48K | -100.03%-39K | 0.00%-39K | 271.44%86.9M | 99.92%-38K | -76,115.73%-67.83M | --154.81M | ---39K | -116.16%-50.69M | 18.35%-50.6M |
| Net common stock issuance | 13,200.13%496.1M | 8.62%2.6M | 822.23%23.61M | 675.80%49.44M | 11,783.97%40.76M | 45.25%3.73M | 48.08%2.39M | 38.53%2.56M | -44.89%6.37M | 34,200.00%343K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | 4,723.41%507.74M | --0 | 5,035.66%31.84M | -3,323.06%-13.66M | 5,437.03%489.57M | 93.50%-10.98M | -45.99%-765K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,637.32%496.05M | -98.22%2.56M | -95.21%23.57M | 1,264.81%644.08M | 179.82%40.72M | -1,859.38%-32.27M | 11,713.83%143.54M | 6,817.91%492.09M | -122.48%-55.3M | 18.36%-51.02M |
| Net cash flow | ||||||||||
| Beginning cash position | -30.79%293.99M | 12.90%348.89M | 44.41%399.27M | -68.19%276.47M | 11.77%352.06M | -18.61%424.79M | -43.04%309.03M | -68.19%276.47M | 118.57%869.19M | -50.23%314.99M |
| Current changes in cash | 155.47%40.26M | -147.43%-54.87M | -254.87%-50.26M | 120.67%122.44M | 219.99%46.88M | 64.86%-72.58M | 673.14%115.69M | 109.94%32.46M | -225.58%-592.3M | -116.53%-39.07M |
| Effect of exchange rate changes | 330.26%350K | -132.86%-23K | -209.62%-114K | 184.21%352K | -39.56%330K | 61.90%-152K | 117.03%70K | 167.53%104K | -276.58%-418K | 902.94%546K |
| End cash Position | -4.96%334.61M | -30.79%293.99M | 12.90%348.89M | 44.41%399.27M | 44.41%399.27M | 11.77%352.06M | -18.61%424.79M | -43.04%309.03M | -68.19%276.47M | -68.19%276.47M |
| Free cash flow | 0.86%-111.3M | -26.90%-140.14M | -6.83%-155.67M | -13.94%-335.52M | 116.03%32.89M | -256.51%-112.26M | -388.70%-110.44M | -314.19%-145.72M | -2,383.06%-294.47M | -202.76%-205.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.